IRCT20230930059562N1已完成3 期
Effect of interfron in the treatment of covid
Imam hossein hospital0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •Patients with Covid pneumonia who needs to hospitalised
排除标准
- •Oxygen saturation percentage above 89%
研究者
相似试验
招募中
3 期
Effect of Fingolimod for treatment of COVID-19-induced cytokine stormCondition 1: Coronavirus (COVID-19)-induced pneumonia. Condition 2: Coronavirus (COVID-19)-induced pneumonia.COVID-19, virus identifiedU07.1J12.8IRCT20200317046797N2Tabriz University of Medical Sciences40
进行中（未招募）
1 期
CLINICAL STUDY IN WHICH PATIENTS ARE RANDOMIZED TO RECEIVE CYCLOSPORINE VS. NON TREATMENT ASSOCIATED TO STANDARD OF CARE TO COMPARE THEIR EFFICACY IN THE COVID-19 PNEUMONIA.COVID-19 PNEUMONIAMedDRA version: 23.1Level: LLTClassification code 10084383Term: Novel COVID-19-infected pneumoniaSystem Organ Class: 100000004862EUCTR2020-002123-11-ESTatiana Cobo Ibáñez174
招募中
不适用
actoferrin in the treatment of Long COVIDong COVIDNL-OMON21473Stichting O&O Franciscus Gasthuis & Vlietland72
招募中
3 期
Trial of novel combined therapy between interferon and hyperlipidemia for chronic hepatitis C patientschronic hepatitis type CJPRN-UMIN000005598Kyoto University Graduate School of Medicine Center for Genomic Medicine100
已完成
不适用
comparison of two drugs for better treatment of covid-19 related lung problemsCTRI/2020/12/029814PRATIMA SINGH90